TY  - CONF

T1  - Adjuvant zoledronic acid (ZOL) in postmenopausal women with breast cancer and those rendered postmenopausal: Results of a meta-analysis

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2012/05/20

AU  - Gregory W

AU  - Marshall H

AU  - Bell R

AU  - Cameron DA

AU  - Coleman RE

ED  - 

VL  - 30

IS  - 15

Y2  - 2025/10/10

ER  -